Early onset type 2 diabetes mellitus: an update

Myrsini Strati,Melpomeni Moustaki,Theodora Psaltopoulou,Andromachi Vryonidou,Stavroula A. Paschou,Paschou, Stavroula A.

DOI: https://doi.org/10.1007/s12020-024-03772-w

2024-03-14

Endocrine

Abstract:The incidence and prevalence of type 2 diabetes mellitus (T2DM) in young individuals (aged <40 years) have significantly increased in recent years, approximating two to threefold increase in the respective rates. Numerous risk factors including severe obesity, family history, ethnicity, maternal diabetes or gestational diabetes, and female sex contribute to a younger age of onset. In terms of pathogenesis, impaired insulin secretion is the key operating mechanism, alongside with ectopic adiposity-related insulin resistance. T2DM diagnosis in a young adult requires the exclusion of type 1 diabetes mellitus (T1DM), latent autoimmune diabetes of adults (LADA) and maturity-onset diabetes of the young (MODY). The establishment of such diagnosis is critical for prognosis, because early-onset T2DM is associated with rapid deterioration in pancreatic β-cell secretory function leading to earlier initiation of insulin therapy. Furthermore, mortality and lifetime risk of developing complications, especially microvascular, is increased in these patients compared to both later-onset T2DM and T1DM patients; also, the latter are often developed earlier in the course of disease. The management of early-onset T2DM follows the same guidelines as in later-onset T2DM; yet patients aged 18–39 years are underrepresented in the big clinical trials on which the development of guidelines is based. Finally, young people with T2DM face significant challenges associated with social determinants, which compromise their adherence to therapy and induce diabetes distress. Future research focusing on the pathogenesis of β-cell decline and complications, as well as on specific treatment shall lead to better understanding and management of early-onset T2DM.

endocrinology & metabolism

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the current situation, risk factors, pathophysiology, clinical manifestations, differential diagnosis, complications and management methods of early - onset type 2 diabetes mellitus (T2DM, age of onset < 40 years). With the significant increase in the incidence of T2DM in the young population in recent years, this disease has attracted wide attention. The paper points out that compared with T2DM with middle - aged and elderly onset, early - onset T2DM has a faster rate of islet β - cell function decline, resulting in an earlier need for insulin treatment, and patients have a higher risk of developing complications at some stage in life, especially microvascular complications. In addition, the management of young T2DM patients faces many challenges, including the impact of social determinants on treatment compliance and the resulting diabetes stress. Future research should focus on the pathogenesis of β - cell function decline and complications, as well as the exploration of specific treatment methods, in order to better understand and manage early - onset T2DM.

The key points of the paper include:

- **Risk factors**: Obesity, family history, specific ethnic background, mother with gestational diabetes or obesity, female gender (especially when accompanied by polycystic ovary syndrome), etc.
- **Pathophysiology**: It mainly involves insulin resistance and β - cell dysfunction. Abnormal fat distribution caused by obesity, fat accumulation in the liver, chronic inflammatory state and other factors exacerbate insulin resistance; in order to compensate for the initial insulin resistance, β - cells will increase insulin secretion, but over time, due to multiple factors (such as glucolipotoxicity, endoplasmic reticulum stress, etc.), the number and secretory capacity of β - cells gradually decline.
- **Clinical manifestations and differential diagnosis**: Early T2DM patients are often accompanied by obesity, metabolic syndrome characteristics, family history, etc., and the disease progresses relatively fast, usually requiring insulin treatment within 2 - 5 years after diagnosis. When making a differential diagnosis, type 1 diabetes, latent autoimmune diabetes in adults (LADA) and maturity - onset diabetes of the young (MODY) need to be excluded.
- **Complications and mortality**: Early T2DM patients have a higher risk of developing complications, especially microvascular complications, and compared with patients with late - onset T2DM or type 1 diabetes, their mortality is also higher.

By reviewing these aspects, the paper aims to improve the understanding of early T2DM and promote the development of more effective prevention and management strategies.